Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.051 AUD | -3.77% |
|
-10.53% | -53.64% |
24/06 | Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6% | MT |
16/04 | Imugene Signs Deal to Sell Manufacturing Facility For $6 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.64% | 25Cr | |
+18.97% | 4.53TCr | |
+41.98% | 4.04TCr | |
-10.06% | 3.79TCr | |
+31.15% | 3.18TCr | |
-7.79% | 2.77TCr | |
+13.32% | 2.65TCr | |
+43.05% | 1.4TCr | |
+31.28% | 1.24TCr | |
-7.41% | 1.13TCr |
- Stock Market
- Equities
- IMU Stock
- News Imugene Limited
- Imugene Names Chief Medical Officer; Shares Rise 3%